TTAB Oppositions 91274741
USPTO Oppositions proceeding 91274741, filed 2022-02-28. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91274741 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2022-02-28 |
| Last Activity | 2022-03-07 |
| Days Active | 1539 |
Parties
- Sorrento Therapeutics, Inc. — Defendant
- Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc. — Plaintiff
Plaintiff Marks
- ALBUSTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- AZOSTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- COMBISTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- DIASTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- HEMA-COMBISTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- HEMASTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- KETOSTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- LABSTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- MULTISTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- MULTISTIX PRO — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
- URISTIX — Ascensia Diabetes Care Holdings AG, Siemens Healthcare Diagnostics, Inc.
Defendant Marks
- COVISTIX — Sorrento Therapeutics, Inc.
Recent Documents
- 2022-03-07: TERMINATED — Status
- 2022-03-07: BD DECISION: OPP SUSTAINED — Decisions
- 2022-02-28: W/DRAW OF APPLICATION — Withdrawals
- 2022-02-28: INSTITUTED — Status
- 2022-02-28: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2022-02-28: FILED AND FEE — Fees